Who makes Beractant instillation?

Beractant instillation is developed by Poznan University of Medical Sciences.

What development phase is Beractant instillation in?

Beractant instillation is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Beractant instillation

Poznan University of Medical Sciences · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Beractant instillation
Sponsor	Poznan University of Medical Sciences
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Less Invasive Beractant Administration in Preterm Infants (NA)
Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Beractant instillation CI brief — competitive landscape report
Beractant instillation updates RSS · CI watch RSS
Poznan University of Medical Sciences portfolio CI